http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1221620-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bcfc53b46a272825132f643216dc7c0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-8117 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e2f4a8974faf7ef41bf7caf347688aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34506a932bc74299ae88e0bf1df0478c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebf4e0ec58ef2ab2eef2a75a07289f33 |
| publicationDate | 2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1221620-A3 |
| titleOfInvention | Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity |
| abstract | A coagulation test for determining the activated clotting time (ACT) of blood in thenpresence of heparin that produces test results that are substantially insensitive to the drugnaprotinin. The activator is formulated to be a combination of celite and bentonite. The ACTnresults obtained with this formulation are similar to celite ACT tests on heparinized blood whilensimultaneously being unaffected by aprotinin. Additionally, a method for quantifying thenaprotinin effect of different ACT formulations is disclosed. |
| priorityDate | 2001-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.